Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C
New York [US], June 2 (ANI): According to a preclinical study conducted by researchers at Weill Cornell Medicine, genetically engineered immune cells successfully targeted the specific cancer cells that may be responsible for relapse of acute myeloid leukaemia (AML), a type of blood cancer,
Washington [US], May 15 (ANI): A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's own immune system to fight tumours.
Washington [US], November 22 (ANI): With a new vaccine approach that would anticipate engineered immune cells from the patient's body, scientists at Scripps Research have moved closer to attaining a triumph over HIV research.
Washington [US], November 20 (ANI): Scientists at Scripps Research have moved closer to attaining a triumph over HIV research with a new vaccine approach that would anticipate engineered immune cells from the patient's body.